QA: Ainos Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001014763_2023_Ainos_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001014763, Ainos Inc.

  xvar xval
0 AssetsCurrent 2,845,917
1 IntangibleAssetsNetIncludingGoodwill 32,806,738
2 PropertyPlantAndEquipmentNet 1,375,676
3 remainder_Assets 80,683
4 LiabilitiesCurrent 2,472,912
5 LiabilitiesNoncurrent 8,096
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 2,114,284
8 SellingGeneralAndAdministrativeExpense 8,535,591
9 ResearchAndDevelopmentExpense 6,845,964
10 remainder_Expenses 0
11 remainder_Revenues 3,519,627
12 remainder_NetIncome -30,478
13 remainder_ComprehensiveNetIncome -207,453
  yvar yval
0 Assets 37,109,014
1 Liabilities 2,481,008
2 Expenses 17,495,839
3 Revenues 3,519,627
4 StockholdersEquity 34,628,006
5 NetIncome -14,006,690
6 ComprehensiveNetIncome -14,110,416
7 BaseVar 30,421,710
8 EconomicCapitalRatio 2.30

Edgar->Model Mapping

Feature Distribution

Change over Time